Title | Stem Cell Transplantation for Hematologic Malignancies [electronic resource] / edited by Robert J. Soiffer |
---|---|
Imprint | Totowa, NJ : Humana Press : Imprint: Humana Press, 2004 |
Connect to | http://dx.doi.org/10.1007/978-1-59259-733-8 |
Descript | X, 486 p. online resource |
I. Transplant for Malignant Disease -- 1 Allogeneic and Autologous Stem Cell Transplantation for Acute Leukemia and Myelodysplasia in the Adult -- 2 Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia -- 3 Stem Cell Transplantation for Hodgkinโs and Non-Hodgkinโs Lymphomas -- 4 Autologous and Allogeneic Transplantation for Multiple Myeloma -- 5 Hematopoietic Progenitor Cell Transplantation for Breast Cancer -- II. Complications of Transplantation -- 6 Pathophysiology of Acute Graft-vs-Host Disease -- 7 Acute Graft-vs-Host Disease -- 8 Chronic Graft-vs-Host Disease After Transplantation -- 9 Immune Reconstitution After Allogeneic Transplantation -- 10 Infection in the Hematopoietic Stem Cell Transplant Recipient -- 11 EBV Lymphoproliferative Disease After Transplantation -- 12 Pathophysiology of Lung Injury After Hematopoietic Stem Cell Transplantation -- 13 Hepatic Veno-Occlusive Disease -- 14 Quality-of-Life Issues Posttransplantation -- III. Sources of Donor Stem Cells -- 15 Stem Cell Sources: Peripheral Blood Stem Cells and Bone Marrow for Allogeneic Transplantation -- 16 Allogeneic Unrelated Donor Blood and Marrow Transplantation -- 17 Haploidentical Stem Cell Transplantation -- 18 Umbilical Cord Hematopoietic Stem Cell Transplantation -- IV. Graft Engineering -- 19 Tumor Contamination of Stem Cell Products: The Role of Purging -- 20 T-Cell Depletion to Prevent Graft-vs-Host Disease -- V. Graft-vs-Tumor Effect -- 21 Donor Lymphocyte Infusions: Clinical Applications and the Graft-vs-Leukemia Effect -- 22 Nonmyeloablative Transplantation